SKI Market

Indian Indices

Nifty

26,186.45 152.70
(0.59%)

Sensex

85,712.37 447.05
( 0.52%)

Bank Nifty

59,777.20 488.50
( 0.82%)

Nifty IT

38,703.65 343.40
( 0.90%)

Global Indices

Nasdaq

47,981.01 109.07
(0.23%)

Dow Jones

6,892.33 14.21
(0.21%)

Hang Seng

50,440.45 -587.97
(-1.15%)

Nikkei 225

9,667.01 -43.86
(-0.45%)

Forex

USD-INR

89.99 -0.14
(-0.16%)

EUR-INR

104.92 -0.11
(-0.11%)

GBP-INR

120.05 0.29
(0.24%)

JPY-INR

0.58 0.00
(0.11%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

92.66

433067.97

EPS(TTM)

Face Value()

Div & Yield %

19.48

0.89

Back

cummins india ltd

BASF India Ltd - Board Meeting Intimation for Board Meeting To Consider And Approve The Standalone And Consolidated Unaudited Financial Results For The Quarter Ending 30Th September 2025

Sep 25,2025

BASF India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results for the quarter ending 30th September 2025

26,186.45 152.70 (0.59%)

85,712.37 447.05 ( 0.52%)

59,777.20 488.50 ( 0.82%)

38,703.65 343.40 ( 0.90%)

47,981.01 109.07 (0.23%)

6,892.33 14.21 (0.21%)

50,440.45 -587.97 (-1.15%)

9,667.01 -43.86 (-0.45%)

89.99 -0.14 (-0.16%)

104.92 -0.11 (-0.11%)

120.05 0.29 (0.24%)

0.58 0.00 (0.11%)